Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating Activities
Net earnings (loss)	$ (136,800,000)	$ 309,900,000	$ 402,600,000
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation	108,900,000	110,200,000	116,500,000
Amortization of intangibles and supply agreements	71,000,000.0	69,600,000	70,800,000
Long-lived asset impairment	443,700,000	0	0
(Decrease) increase in provision for losses on accounts and notes receivable	(6,500,000)	3,200,000	(3,400,000)
Writedown of inventories	9,000,000.0	17,100,000	13,700,000
Net gain from disposal of assets and businesses	(20,100,000)	(2,500,000)	(29,400,000)
Deferred income tax benefit	(129,200,000)	(15,700,000)	(8,500,000)
Stock-based compensation	27,600,000	30,100,000	34,200,000
Other, net	13,600,000	(2,500,000)	12,400,000
Changes in working capital, excluding effects from acquisitions and divestitures:
Accounts and other receivables	48,600,000	(26,600,000)	(75,000,000.0)
Inventories	86,500,000	96,100,000	(305,000,000.0)
Other current assets	4,000,000.0	(3,700,000)	(6,700,000)
Accounts payable	13,700,000	(102,100,000)	63,500,000
Accrued expenses and other current liabilities	(36,800,000)	(41,700,000)	(14,400,000)
Net Cash Provided by Operating Activities	497,200,000	441,400,000	271,300,000
Investing Activities
Additions to property, plant and equipment	(113,800,000)	(100,300,000)	(106,600,000)
Purchases of companies, net of cash acquired	0	(83,300,000)	(152,600,000)
Proceeds from sales of assets and businesses	23,400,000	4,200,000	38,500,000
Other, net	(900,000)	(1,800,000)	(5,500,000)
Net Cash Used for Investing Activities	(91,300,000)	(181,200,000)	(226,200,000)
Financing Activities
Additions to long-term debt	700,000	4,700,000	492,800,000
Payments on long-term debt	(2,000,000.0)	(301,500,000)	(306,600,000)
Change in commercial paper and short-term debt	(105,800,000)		(1,300,000)
Change in commercial paper and short-term debt		301,800,000
Dividends paid	(239,400,000)	(229,200,000)	(218,300,000)
Issuances of common stock	0	0	3,500,000
Purchases of common stock	(6,000,000.0)	(60,300,000)	(9,800,000)
Proceeds from interest rate treasury lock	0	0	10,200,000
Other, net	(6,300,000)	(1,700,000)	(3,300,000)
Net Cash Used for Financing Activities	(358,800,000)	(286,200,000)	(32,800,000)
Effect of Exchange Rate Changes on Cash	1,900,000	(19,200,000)	500,000
Increase (Decrease) in Cash and Cash Equivalents	49,000,000.0	(45,200,000)	12,800,000
Cash and Cash Equivalents—Beginning of Year	316,500,000	361,700,000	348,900,000
Cash and Cash Equivalents—End of Year	365,500,000	316,500,000	361,700,000
Supplemental Information
Interest paid (net of amounts capitalized)	85,800,000	84,000,000.0	66,600,000
Income taxes paid	98,800,000	125,200,000	126,800,000
Property, plant and equipment acquired through finance leases	1,400,000	1,400,000	1,900,000
Capital expenditures in accounts payable	3,200,000	3,600,000	4,300,000
Prepaid income taxes and taxes receivable applied against the deemed repatriation tax liability	$ 9,500,000	$ 6,100,000	$ 4,000,000.0